Advertisement

Oncology

An AI-empowered blood test was able to more reliably identify ovarian cancer by detecting DNA fragments and protein biomarkers, according to a study published Sept. 30 in the American Association for Cancer Research's journal, Cancer Discovery.

The FDA's Oncologic Drugs Advisory Committee has voted to restrict the use of nivolumab and pembrolizumab immunotherapy drugs based on the programmed death-ligand 1 expression levels of patients, according to a Sept. 30 Medscape report. 

Advertisement

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates among pediatric populations.

Rockledge, Fla.-based Health First will transfer ownership of its Health First Cancer Institute building to Titusville, Fla.-based Parrish Healthcare as part of the health systems' collaboration. 

Houston-based University of Texas MD Anderson Cancer Center is publishing an open-access, peer-reviewed academic journal. Advances in Cancer Education & Quality Improvement will share research and insights with the aim of improving cancer care and patient outcomes. 

Chicago-based Northwestern Medicine has named Hidayatullah Munshi, MD, chief of the hematology and oncology division in the Department of Medicine at the Feinberg School of Medicine. 

Advertisement